» Articles » PMID: 19361040

Lignocaine: Neuro-protective or Wishful Thinking?

Overview
Publisher EDP Sciences
Date 2009 Apr 14
PMID 19361040
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Peri-operative brain injury continues to occur in cardiac surgery despite a significant effort in preventative research spanning 50 years. There has been much interest in pharmacologic neuro-protection. Six drugs, thiopentone, prostacyclin, nimodipine, remacemide, lignocaine, and Glypromate, have been the subject of one or more randomized controlled trials (RCTs). Only the results for Glypromate are unknown at this stage. In all other cases, the studies have been negative, equivocal, or initially positive but followed by negative studies. Lignocaine is arguably the most extensively studied. In vitro and in vivo experiments that proved lignocaine to be neuro-protective were followed by two RCTs that showed reductions in post-operative cognitive deficits. However, two further RCTs have failed to demonstrate benefit. Lignocaine cannot be recommended for neuro-protection in cardiac surgery at this time, but a role in clinical neuro-protection in this or other contexts is not ruled out.

Citing Articles

Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences.

Silva-Reis S, Sampaio-Dias I, Costa V, Correia X, Costa-Almeida H, Garcia-Mera X ACS Chem Neurosci. 2023; 14(4):554-572.

PMID: 36735764 PMC: 9936549. DOI: 10.1021/acschemneuro.2c00675.


Protective role of lidocaine against cerebral ischemia-reperfusion injury: An study.

Lan X, Xu Y Exp Ther Med. 2021; 23(1):42.

PMID: 34849157 PMC: 8613535. DOI: 10.3892/etm.2021.10964.


Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial.

Klinger R, Cooter M, Bisanar T, Terrando N, Berger M, Podgoreanu M Anesthesiology. 2019; 130(6):958-970.

PMID: 30870159 PMC: 6520120. DOI: 10.1097/ALN.0000000000002668.


Cardiac surgery, the brain, and inflammation.

Scott D, Evered L, Silbert B J Extra Corpor Technol. 2014; 46(1):15-22.

PMID: 24779114 PMC: 4557505.

References
1.
Rogers A . Con: preventing stroke after cardiopulmonary bypass does not require pharmacologic neuroprotection. J Cardiothorac Vasc Anesth. 1997; 11(6):796-800. DOI: 10.1016/s1053-0770(97)90178-6. View

2.
Forsman M, Olsnes B, Semb G, Steen P . Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth. 1990; 65(4):514-20. DOI: 10.1093/bja/65.4.514. View

3.
Warner D, Godersky J, Smith M . Failure of pre-ischemic lidocaine administration to ameliorate global ischemic brain damage in the rat. Anesthesiology. 1988; 68(1):73-8. DOI: 10.1097/00000542-198801000-00012. View

4.
Wang D, Wu X, Li J, Xiao F, Liu X, Meng M . The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg. 2002; 95(5):1134-41, table of contents. DOI: 10.1097/00000539-200211000-00002. View

5.
Nishina K, Mikawa K, Takao Y, Shiga M, Maekawa N, Obara H . Intravenous lidocaine attenuates acute lung injury induced by hydrochloric acid aspiration in rabbits. Anesthesiology. 1998; 88(5):1300-9. DOI: 10.1097/00000542-199805000-00022. View